Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Tenforde, Mark W., Weber, Zachary A., Natarajan, Karthik, Klein, Nicola P., Kharbanda, Anupam B., Stenehjem, Edward, Embi, Peter J., Reese, Sarah E., Naleway, Allison L., Grannis, Shaun J., DeSilva, Malini B., Ong, Toan C., Gaglani, Manjusha, Han, Jungmi, Dickerson, Monica, Fireman, Bruce, Dascomb, Kristin, Irving, Stephanie A., Vazquez-Benitez, Gabriela, Rao, Suchitra, Konatham, Deepika, Patel, Palak, Schrader, Kristin E., Lewis, Ned, Grisel, Nancy, McEvoy, Charlene, Murthy, Kempapura, Griggs, Eric P., Rowley, Elizabeth A. K., Zerbo, Ousseny, Arndorfer, Julie, Dunne, Margaret M., Goddard, Kristin, Ray, Caitlin, Zhuang, Yan, Timbol, Julius, Najdowski, Morgan, Yang, Duck-Hye, Hansen, John, Ball, Sarah W., Link-Gelles, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812442/
https://www.ncbi.nlm.nih.gov/pubmed/36580430
http://dx.doi.org/10.15585/mmwr.mm715152e1
Mostrar todas las versiones(2)

Ejemplares similares